This online educational activity is directed toward ophthalmologists and retinal specialists. Other health care professionals involved in the treatment of patients with nAMD are also invited to participate.
Medical Crossfire™, one of PER’s signature educational formats, is a video-based program in which a panel of distinguished experts engage in spirted discussions about a clinical topic. In this activity, four thought leaders explore the emerging data surrounding sustained-delivery anti-vascular endothelial growth factor (Anti-VEGF) therapies for the management of neovascular retinal diseases like neovascular age-related macular degeneration (nAMD). This lively debate will place new developments into clinical context to help you optimize care for patients with neovascular retinal diseases.
Upon completion of this activity, participants should be better able to: